Introduction
============

Parameters related to adequacy of dialysis are numerous, and simply monitoring one of them is insufficient. Considering the impact of adequacy of dialysis on quality of life, rigorous attempts to achieve the desired goals are necessary.[@b1-ijnrd-8-059],[@b2-ijnrd-8-059] Awareness of how and the extent to which hemodialysis (HD) affects the microcirculation in skeletal muscle may be clinically important. Changes in the microcirculation have been recorded, particularly in patients suffering from diabetes mellitus,[@b3-ijnrd-8-059],[@b4-ijnrd-8-059] arterial hypertension,[@b5-ijnrd-8-059] and peripheral arterial disease.[@b6-ijnrd-8-059] In particular, near infrared spectroscopy (NIRS) in combination with the vascular (arterial and venous) occlusion test (VOT) is a simple method for monitoring peripheral tissue oxygenation at the bedside, the tissue oxygen consumption rate at ischemia, and meaning and the functionality and integrity of the endothelium.[@b6-ijnrd-8-059],[@b7-ijnrd-8-059] NIRS has been used in various clinical situations, including in intensive care patients,[@b6-ijnrd-8-059],[@b8-ijnrd-8-059],[@b9-ijnrd-8-059] patients with chronic heart failure,[@b7-ijnrd-8-059],[@b10-ijnrd-8-059] and healthy volunteers.[@b11-ijnrd-8-059]--[@b13-ijnrd-8-059]

The purpose of this study was to assess the effects of HD or hemodiafiltration (HDF) on the thenar microcirculation in patients with end-stage renal disease (ESRD) and with or without diabetes receiving maintenance HD (as estimated by NIRS and VOT), to investigate the possible relationship between changes in the microcirculation and adequacy of dialysis (including Kt/V and parameters associated with secondary hyperparathyroidism), and to compare NIRS measurements obtained from ESRD patients with those in healthy controls. Monitoring of the microcirculation may add additional information in terms of improving the adequacy of HD for patients.

Materials and methods
=====================

Selection of subjects
---------------------

We conducted a prospective observational pilot study among ESRD patients undergoing regular dialysis sessions. Patients were excluded if they were younger than 18 years of age, had a high body mass index (≥35 kg/m^2^), and had generalized edema. Demographic details and data on dialysis parameters were recorded for all patients. Healthy volunteers were screened by clinical history, physical examination, and routine chemical analysis. None showed present or past evidence of diabetes, hypercholesterolemia, chronic renal failure, peripheral artery disease, or cardiovascular disease. All patients enrolled in the study were asked to refrain from caffeine-containing drinks for at least 2 hours before the start of measurements. Informed consent was obtained from all study participants.

Measurement protocol
--------------------

Two paired microcirculation assessments were recorded for each HD patient just prior to the start and at the end of one mid-week dialysis session. The pre-dialysis assessment started before insertion of arterial and venous lines in a sitting position. NIRS was used to measure thenar muscle oxygen saturation before, during, and after brachial artery occlusion on the hand contralateral to arteriovenous access placement. Each patient's pre-dialysis and post-dialysis blood pressure and weight were also noted. Routine blood samples were collected pre-dialysis and post-dialysis when the pump slowed down and before the lines were flushed with saline. Serum calcium, phosphorus, and parathyroid hormone were measured at the beginning of the HD session. The measurement of the second microcirculation was performed using VOT after removal of the HD lines and in the sitting position. Single-pool Kt/V was calculated by using pre-dialysis and post-dialysis urea, duration often a single HD session and ultrafiltration removal over the same session.

Analysis of tissue oxygen saturation (StO~2~) curves and estimation of the adequacy of dialysis were then performed using single-pool Kt/V. Percentage change in the parameters was estimated by subtraction of pre-dialysis (baseline) values from post-dialysis values divided with pre-dialysis values and multiplied by 100. NIRS variables were measured in healthy seated volunteers.

Near infrared spectroscopy and the vascular occlusion test
----------------------------------------------------------

NIRS is a promising, easily applicable, noninvasive system for monitoring of the microcirculation in skeletal muscle. It is based on the capacity of hemoglobin to absorb infrared light at different and well separated wavelengths (680--800 nm). By illuminating and collecting back- scattered light from tissue, NIRS methodology can determine the percentage of oxyhemoglobin in total hemoglobin (oxygenated or not oxygenated) for a certain tissue volume (StO~2~).[@b12-ijnrd-8-059] Infrared light can penetrate to a depth of 12.5 cm, allowing accurate measurement of skeletal muscle StO~2~ while ignoring the superjacent skin and subcutaneous microcirculation.[@b13-ijnrd-8-059]

In the present study, thenar StO~2~ was measured non-invasively using a second-generation NIRS device (Inspectra Model 325, Hutchinson Technology, McLeod County, MN, USA). First, a sphygmomanometer cuff was placed around the patient's arm, and a transdermal light probe was placed on the patient's ipsilateral thenar area. Baseline arterial pressure and StO~2~ were then recorded after a 3-minute stabilization period. Next, ischemia was introduced by rapid inflation of the pneumatic cuff to 50 mmHg above the patient's systolic blood pressure. Vascular occlusion (mostly of the brachial artery) was maintained for 3 minutes, during which the decrease in thenar StO~2~ was recorded (ischemia phase). The cuff was then rapidly deflated, noting an increase in thenar StO~2~ (reperfusion phase). Monitoring was continued until StO~2~ returned to its baseline value (hyperemia phase).[@b12-ijnrd-8-059] The StO~2~ data were retrospectively analyzed using the software provided by the manufacturer (Inspectra Analysis Program version 4.01, Hutchinson Technology). Linear regression analysis was used to estimate the VOT-derived StO~2~ parameters, the rate of hemoglobin desaturation during ischemia (oxygen consumption rate, percent per minute), the StO~2~ growth curve during reperfusion, which represents microvascular and precapillary sphincter reactivity (endothelial function, percent per second), and the hyperemia phase (vascular reactivity).[@b11-ijnrd-8-059]

Statistical analysis
--------------------

Measurements before and after the HD session were compared by paired *t*-test, and the χ^2^ or Fisher's Exact test was used to compare nominal variables. Descriptive characteristics and results from the three subject groups were compared by analysis of variance. Comparative analysis between the groups was performed by analysis of variance with a Bonferroni post hoc test. Correlation analysis was done by Pearson's analysis for normally distributed datasets. Differences between groups were considered to be statistically significant at *P*\<0.05. All data are presented as the mean ± standard deviation.

Results
=======

Twenty-eight subjects were enrolled in the study. Eleven were ESRD patients who had been on maintenance HD for 4.5±3 years (nine males and two females, mean age 73.0±10.5 years, mean body mass index 27.0±0.3, including ten \[91%\] with hypertension and none with diabetes), nine were ESRD patients who had been on maintenance HDF for 4.0±2.5 years (six males and three females, mean age 65.5±13.2 years, body mass index 24.0±03.7, including five \[55.5%\] with diabetes, four \[44.5%\] with hypertension, and two with coexisting hypertension and diabetes), and eight were healthy volunteers. Baseline demographic data and clinical characteristics for all patients and healthy subjects are presented in [Table 1](#t1-ijnrd-8-059){ref-type="table"}. All ESRD patients with hypertension were treated with nifedipine 5--15 mg/day. Other antihypertensive medications were not administered. All dialyzers were made of polysulfone with a membrane surface area of 1.5±0.2 m^2^, with the dialysate flow rate and temperature stable at 500 mL per minute and 36°C, respectively. Low molecular weight heparin was used for anticoagulation. HDF was of low volume at 30±5 mL/kg/hour. The characteristics of the ESRD patients receiving HD or HDF are summarized in [Tables 2](#t2-ijnrd-8-059){ref-type="table"} and [3](#t3-ijnrd-8-059){ref-type="table"}. Kt/V was not calculated in eight of the eleven patients on HD due to three missing sets of post-dialysis urea values.

Patients on HD showed an increased oxygen consumption rate after their 4-hour HD session (coefficient of variation 8.8%, [Table 2](#t2-ijnrd-8-059){ref-type="table"}) and the percent change in oxygen consumption rate were positively correlated with the single-pool Kt/V (*R*=0.74, *P*=0.03, [Figure 1](#f1-ijnrd-8-059){ref-type="fig"}). Further, in this patient group, the pre-dialysis StO~2~ was positively correlated with pre-dialysis serum parathyroid hormone (*R*=0.70, *P*=0.02) and calcium (*R*=0.90, *P*\<0.0001, [Figures 2](#f2-ijnrd-8-059){ref-type="fig"} and [3](#f3-ijnrd-8-059){ref-type="fig"}). NIRS variables did not differ before and after a 4-hour HDF session ([Table 3](#t3-ijnrd-8-059){ref-type="table"}). Statistically significant differences in the pre-dialysis microcirculation were noted between patients with ESRD and healthy controls. Pre-dialysis endothelial function was lower in patients with ESRD (coefficient of variation 9.3%, [Table 1](#t1-ijnrd-8-059){ref-type="table"}).

Discussion
==========

The finding of this study that extends our current knowledge is the correlation between the improvement in cell metabolism conferred by a single HD session and adequacy of dialysis as indicated by the single-pool Kt/V. A possible explanation for this relationship is that HD rapidly clears uremic toxins as well as markers of endothelial damage (circulating endothelial microparticles),[@b5-ijnrd-8-059] given that patients with ESRD have high levels of both.[@b14-ijnrd-8-059] This result confirms our original hypothesis based on the work of Kong and Farrington,[@b15-ijnrd-8-059] who suggested that clearance of substances during HD occurs not only at the level of the dialyzer but also at the level of the capillary membrane. Bearing in mind that nutrition, acidosis, and ultrafiltration rate are additional markers of the adequacy of dialysis, our results are consistent with those of previous studies showing that cutaneous blood flow is associated with albumin levels in patients on HD[@b16-ijnrd-8-059] and that changes in the sublingual microcirculation are related to changes in volume during the HD procedure.[@b17-ijnrd-8-059] Further, Kemp et al[@b18-ijnrd-8-059] showed that the urea reduction ratio was negatively correlated with body mass index, reflecting the effect of muscle mass on the efficiency of dialysis.

The increased cell metabolism seen at the end of a HD session could be caused by the acute withdrawal of liquid taking place during HD, which reduces interstitial edema and the external pressure on the microcirculation, also triggering an increased dilatation of the peripheral capillaries.[@b19-ijnrd-8-059] Vascular dilatation can be further provoked by complement activation and endothelial production of cytokines and prostacyclins, which occurs during HD,[@b17-ijnrd-8-059],[@b20-ijnrd-8-059] as well as by administration of vasodilating antihypertensives,[@b4-ijnrd-8-059] which were common in our patient sample (70% of the ESRD patients were on calcium antagonist therapy). The improvement in thenar cell metabolism may also be related to the increase in oxygenated hemoglobin levels at the end of the HD session. The affinity of hemoglobin for oxygen can be affected indirectly by extracellular agents, such as phosphorus and plasma pH. It has been documented that the ability of hemoglobin to bind to oxygen is limited under conditions of acidosis and hyperphosphatemia, which are present in the pre-dialysis period, but improves after HD because of a reduction in phosphorus levels and an increase in pH.[@b21-ijnrd-8-059] Interestingly, improvement in the microcirculation was not observed in patients on maintenance hemodiafiltration. The heterogeneity of patients in this group, ie, presence of diabetes with or without hypertension, might have affected our findings. The influence of heparin in the microcirculation cannot be evaluated since it was administered to all patients.

In the literature, the majority of studies that have investigated the impact of HD on the smallest vessels have referred to microcirculation in the skin.[@b17-ijnrd-8-059],[@b22-ijnrd-8-059]--[@b24-ijnrd-8-059] Most of these data indicate that the microcirculation in the skin deteriorates during the HD procedure[@b17-ijnrd-8-059],[@b22-ijnrd-8-059]--[@b24-ijnrd-8-059] and patients with diabetes and peripheral arterial occlusive disease are more susceptible to impairments in the peripheral microcirculation and are at high risk of gangrene.[@b23-ijnrd-8-059]--[@b25-ijnrd-8-059] Changes in the skeletal muscle microcirculation during a HD session have been recorded by De Βlasi et al[@b4-ijnrd-8-059] using a NIRS device (NIMO-4 tissue probe; Nirox Srl, Brescia, Italy). They evaluated changes in the microcirculation in 20 ESRD patients (half of whom were diabetic) on HD before and every hour during a 4-hour HD session. In their study, the NIRS probe was applied to the gastrocnemius muscle and VOT was performed on the ipsilateral thigh and ankle. They demonstrated improvement of oxygen consumption rate in their diabetic patients but not in their nondiabetic population, as we did in our study. Differences in methodology, ie, use of a different NIRS technique and application of a probe to other muscle groups, contributed to the dissimilar outcomes. Our results are in agreement that StO~2~ remained unchanged after the HD procedure.

Another important finding of our study is the association between serum calcium and parathyroid hormone levels and the pre-dialysis StO~2~ during HD, which reflects the localized equilibrium of oxygen delivery and utilization. Serum calcium is tightly regulated by parathyroid hormone, and dysregulation of this balance contributes to the development of secondary hyperparathyroidism, which in turn causes bone disease and vascular calcification in patients with ESRD, and eventually increases mortality and morbidity.[@b26-ijnrd-8-059] Changes in the microcirculation may promote extension of the consequences of calcification in patients with ESRD and adversely affect many organs. This result is in agreement with the observation by Sigrist et al,[@b27-ijnrd-8-059] who have already highlighted the relationship between dysfunction in the microcirculation of the skin and vascular calcification in patients on HD. These authors also suggest that common pathological factors could take part in both vascular calcification and microcirculatory dysfunction, resulting in progression of the cardiovascular disease associated with ESRD.

Ultimately, in our study, patients with ESRD showed deterioration of the microcirculation at the level of the endothelium when compared with healthy subjects. Patients with ESRD are permanently exposed to uremic toxins which are poorly removed by HD and induce endothelium-dependent vasodilatation, elevated soluble biomarkers of endothelial dysfunction, and increased oxidative stress.[@b19-ijnrd-8-059],[@b28-ijnrd-8-059],[@b29-ijnrd-8-059] Traditional risk factors, such as age and hypertension, have been associated with changes in endothelial function,[@b30-ijnrd-8-059],[@b31-ijnrd-8-059] and therefore might be responsible for modification of vascular elasticity. Further, hypertensive patients on HD may have more severe vascular damage, because in parallel with progression of endothelial impairment, these patients show a decrease in total vascular dilatative capacity.[@b5-ijnrd-8-059] Exercise training could be an effective option for improvement of mitochondrial oxidative capacity in patients on HD.[@b32-ijnrd-8-059]

The limitations of this study include its small and heterogeneous patient population, and the lack of additional paired measurements that could have be recorded during more HD sessions. Further, the proportions in the sample did not help to minimize the confounding effects of age, sex, and diabetes history. Recording of pH changes during the HD session would potentially have further clarified the changes in microcirculation.

Overall, in this NIRS study, we documented acute improvement of baseline thenar cell metabolism over a 4-hour HD session, which correlated with single-pool Kt/V of a single treatment, and a positive relationship between pre-dialysis serum calcium and parathyroid hormone levels and changes in tissue oxygenation at steady state. These preliminary findings need to be tested using a larger data set. While useful markers often fail to provide direct evidence of dialysis adequacy, combination with evaluation of the microcirculation may provide additional information for the handling of patients on HD and novel targets for treatment. Interestingly, patients on HD showed impaired endothelial integrity when compared with healthy subjects.
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![Correlation between increased OCR, ie, thenar cell metabolism at rest during a single mid-week hemodialysis session, and Kt/V as a marker of the adequacy of hemodialysis (*R*=0.74, *P*=0.03).\
**Abbreviation:** OCR, oxygen consumption rate.](ijnrd-8-059Fig1){#f1-ijnrd-8-059}

![Changes in thenar tissue oxygen saturation over a single hemodialysis session correlate positively with PTH levels in patients undergoing hemodialysis (*R*=0.70, *P*=0.02).\
**Abbreviation:** PTH, parathyroid hormone.](ijnrd-8-059Fig2){#f2-ijnrd-8-059}

![Changes in thenar tissue oxygen saturation over a single hemodialysis procedure correlate positively with pre-dialysis serum calcium levels in patients undergoing hemodialysis (*R*=0.90, *P*\<0.0001).](ijnrd-8-059Fig3){#f3-ijnrd-8-059}

###### 

Near infrared spectroscopy variables in patients with ESRD and in healthy volunteers

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                               ESRD\                                                 Healthy volunteers\                                    *P*-value
                                               (n=20)                                                (n=8)                                                  
  -------------------------------------------- ----------------------------------------------------- ------------------------------------------------------ -----------
  Age, years (mean ± SD)                       69.5±12.0                                             28.0±4.0                                               \<0.0001

  Sex (M/F)                                    15/5                                                  8/0                                                    0.221

  BMI, kg/m^2^ (mean ± SD)                     26.0±3.4                                              28.0±4.0                                               0.192

  Diabetes                                     5 (25%)                                               0                                                      0.65

  Hypertension                                 14 (70%)                                              0                                                      \<0.0001

  Tissue oxygen saturation, % (mean ± SD)      79.6±14.3                                             80.3±6.0                                               0.32

  Oxygen consumption rate, %/min (mean ± SD)   −31.4±19.2                                            −37.7±5.5                                              0.53

  Endothelial function, %/min (mean ± SD)      9.1±5.6[\*](#tfn2-ijnrd-8-059){ref-type="table-fn"}   15.7±6.3[\*](#tfn2-ijnrd-8-059){ref-type="table-fn"}   0.003
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** One-way analysis of variance and Bonferroni post hoc test were used to test for statistically significant differences among groups. The statistical difference was set at *P*\<0.05.

*P*=0.005 between ESRD and healthy volunteers.

**Abbreviations:** BMI, body mass index; ESRD, end-stage renal disease; M, male; F, female; SD, standard deviation.

###### 

Hemodynamic and biochemical characteristics of HD session (n=11)

                                    Before start of HD session   After end of HD session   *P*-value
  --------------------------------- ---------------------------- ------------------------- --------------
  Systolic arterial                 125.5±13.7                   120.8±10.3                0.264
  BP (mmHg)                                                                                
  Weight (kg)                       77.8±8.1                     76.1±7.8                  \<**0.0001**
  Hematocrit (%)                    37.2±3.6                     39.2±6.9                  0.150
  Urea (mg/dL)                      192.6±50.4                   76.7±37.8                 \<**0.0001**
  Creatinine (mg/dL)                9.7±2.5                      4.4±1.5                   \<**0.0001**
  Calcium (mg/dL)                   8.8±1.7                      N/A                       
  Phosphorus (mg/dL)                5.6±2.0                      N/A                       
  Parathyroid hormone (pg/mL)       483.0±297.5                  N/A                       
  Kt/V per session                  1.1±0.3                                                
  Tissue oxygen saturation (%)      81.8±11.9                    74.4±4.5                  0.113
  Oxygen consumption rate (%/min)   24.5±7.5                     40±17.7                   **0.030**
  Endothelial function (%/min)      9.9±5.5                      11.4±6.5                  0.062

**Notes:** Bold represent statistically significant figures. Values are presented as mean ± standard deviation.

**Abbreviations:** BP, blood pressure; HD, hemodialysis; N/A, not applicable.

###### 

Hemodynamic and biochemical characteristics of hemodiafiltration session (n=9)

                                    Before start of HD session   After end of HD session   *P*-value
  --------------------------------- ---------------------------- ------------------------- --------------
  Systolic arterial                 136.6±25.9                   111.2±17.2                **0.046**
  BP (mmHg)                                                                                
  Weight (kg)                       77.8±16.9                    76±12.5                   \<**0.0001**
  Hematocrit (%)                    39.4±2.6                     41±4                      0.203
  Urea (mg/dL)                      144.1±35.3                   47.6±19.8                 \<**0.0001**
  Creatinine (mg/dL)                7.7±2.5                      2.9±1.3                   \<**0.0001**
  Calcium (mg/dL)                   9.4±1.3                      N/A                       
  Phosphorus (mg/dL)                5.6±2                        N/A                       
  Parathyroid hormone (pg/mL)       483.1±297.5                  N/A                       
  Tissue oxygen saturation (%)      77.9±16.9                    76±12.5                   0.765
  Oxygen consumption rate (%/min)   39.6±20.9                    53.4±33.8                 0.276
  Reperfusion rate (%/min)          9.1±5.7                      7.1±3.8                   0.543

**Notes:** Bold represent statistically significant figures. Values are presented as mean ± standard deviation.

**Abbreviations:** BP, blood pressure; HD, hemodialysis; N/A, not applicable.
